| Institution: | 1. Public Health Unit: Risk Management and Quality of Care, Paris Centre University Hospital Group, AP‐HP, Paris, France;2. Department of Public Health, Faculty of Medicine, Paris Descartes University, Sorbonne Paris Cité, Paris, France;3. Research Unit (INSERM U1153) Methods Team, Methods of Therapeutic Evaluation of Chronic Diseases, Research Center Epidemiology and Biostatistics, Sorbonne Paris Cité, Paris, France;4. Hepatogastroenterology Department, CHG du Mans, Le Mans, France;5. Hepatogastroenterology Department, CHU de Brest, Brest, France;6. Hepatogastroenterology Department, CHG de Versailles, Versailles, France;7. Hepatogastroenterology Department, CHU Kremlin Bicètre, Kremlin Bicètre, France;8. Hepatogastroenterology Department, CHG de Poissy, Poissy, France;9. Centre de Reference en Addictologie, Pitie‐Salpetriere Hospital, AP‐HP, Paris Descartes University, Paris, France;10. Hepatogastroenterology Department, CHG de Bagnoles sur Cèze, Bagnoles sur Cèze, France;11. Hepatogastroenterology Department, CHG de Carcassonne, Carcassonne, France |
